News Formal

AbbVie leans on new treatments to forecast upbeat 2020 profit

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 66%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

AbbVie Inc on Friday forecast 2020 earnings above Wall Street estimates as the drugmaker expects growth to be powered by its new treatments for ...

AbbVie Inc on Friday forecast 2020 earnings above Wall Street estimates as the drugmaker expects growth to be powered by its new treatments for psoriasis and rheumatoid arthritis at a time when sales of its blockbuster drug Humira slow.

"The launches of Skyrizi and Rinvoq are going extremely well," Chief Executive Officer Richard Gonzalez said in a statement. Quarterly sales of the blockbuster drug were largely unchanged compared with a year earlier at US$4.92 billion. But it beat expectations of US$4.85 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Budget 2020 will help those hit by coronavirus outbreak: IndraneeSGBudget2020 will help those hit by coronavirus outbreak: Indranee
Source: BusinessTimes - 🏆 15. / 51 Read more »